Notably, 2 glioblastoma patients (IDH, MGMT positive and IDH negative, MGMT positive, respectively) without residual tumor after resection presented with low blood flow (mTBF<100 ml/100 g/min). This evidence concerns the gene MGMT and neoplasm.